Sampling and recruitment in multilevel studies among marginalized urban populations: The IMPACT studies

Journal of Urban Health

Volumn 85, Issue 2, 2008, Pages 268-280

  Ompad, Danielle C ^a   Galea, Sandro ^a,b   Marshall, Grant ^c   Fuller, Crystal M ^a,d   Weiss, Linda ^a   Beard, John R ^a   Chan, Christina ^a   Edwards, Vincent ^a   Vlahov, David ^a,d  

^a NEW YORK ACADEMY OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c RAND CORPORATION   (United States)

^d Columbia University ^*  (United States)

Author keywords

Drug users; Marginalized populations; Multilevel studies; Neighborhoods; Recruitment; Sampling

Indexed keywords

ARTICLE; DRUG USE; ETHNICITY; HEALTH CARE ORGANIZATION; HUMAN; INTERVIEW; MEDICAL RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; SAMPLING; URBAN AREA;

ADULT; BLOOD-BORNE PATHOGENS; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; POVERTY AREAS; RESIDENCE CHARACTERISTICS; SAMPLING STUDIES; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; TRANSIENTS AND MIGRANTS; URBAN HEALTH;

EID: 40549126327     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-008-9256-0     Document Type: Article

References (33)

1. Hembree C, Galea S, Ahern J, et al. The urban built environment and overdose mortality in New York City neighborhoods. Health Place. 2005;11(2):147-156.
2. Galea S, Ahern J, Vlahov D, et al. Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug Alcohol Depend. 2003;70(2):139-148.
3. Cooper HL, Friedman SR, Tempalski B, Friedman R. Residential segregation and injection drug use prevalence among black adults in US metropolitan areas. Am J Public Health. 2007;97(2):344-352.
4. Diez Roux AV. Investigating neighborhood and area effects on health. Am J Public Health. 2001;91(11):1783-1789.
5. Krieger N, Waterman P, Chen JT, Soobader MJ, Subramanian SV, Carson R. Zip code caveat: bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas-the Public Health Disparities Geocoding Project. Am J Public Health. 2002;92(7):1100-1102.
6. Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156(5):471-482.
7. Friedman SR, Flom PL, Kottiri BJ, et al. Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction. 2003;98(2):159-169.
8. Inciardi JA, Surratt HL, Kurtz SP. HIV, HBV, and HCV infections among drug-involved, inner-city, street sex workers in Miami, Florida. AIDS Behav. 2006;10(2):139-147.
9. Davidson PJ, McLean RL, Kral AH, Gleghorn AA, Edlin BR, Moss AR. Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention. J Urban Health. 2003;80(2):261-273 June.
10. Galea S, Nandi A, Vlahov D. The social epidemiology of substance use. Epidemiol Rev. 2004;26:36-52.
11. Latkin CA, Curry AD, Hua W, Davey MA. Direct and indirect associations of neighborhood disorder with drug use and high-risk sexual partners. Am J Prev Med. 2007;32(6 Suppl):S234-S241.
12. Winstanley EL, Steinwachs DM, Ensminger ME, Latkin CA, Stitzer ML, Olsen Y. The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment. Drug Alcohol Depend. 2008;92(1-3):173-182.
13. van de Goor LA, Garretsen HF, Kaplan C, Korf D, Spruit IP, de Zwart WM. Research methods for illegal drug use in hidden populations: summary report of a European invited expert meeting. J Psychoactive Drugs. 1994;26(1):33-40.
14. Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. J Social Problems. 1989;36(4):416-430.
15. Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174-199.
16. Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. J Soc Prob. 1989;36:416-430.
17. Weiss L, Ompad D, Galea S, Vlahov D. Defining neighborhood boundaries for urban health research. Am J Prev Med. 2007;32(6 Suppl):S154-S159.
18. Miller KW, Wilder LB, Stillman FA, Becker DM. The feasibility of a street-intercept survey method in an African-American community. Am J Public Health. 1997;87(4):655-658.
19. Robins LN, Cottler L, Bucholz K, Compton W. Diagnostic interview schedule for DSM-IVSt. Louis: Washington University; 1995.
20. Freedy JR, Kilpatrick DG, Resnick HS. Natural disasters and mental health: theory, assessment, and intervention. J Soc Behav Personal. 1993;8(5):49-103.
21. Acierno R, Kilpatrick DG, Resnick H, Saunders B, De Arellano M, Best C. Assault, PTSD, family substance use, and depression as risk factors for cigarette use in youth: findings from the National Survey of Adolescents. J Trauma Stress. 2000;13(3):381-396.
22. U.S. Census Bureau. U.S. Census 2000. U.S. Department of Commerce, Economic and Statistics Administration.
23. Bryant WK, Ompad DC, Sisco S, et al. Determinants of influenza vaccination in hard-to-reach urban populations. Prev Med. 2006;43(1):60-70.
24. Fuller CM, Ompad DC, Galea S, Wu Y, Koblin BA, Vlahov D. Hepatitis C incidence-a comparison between injection and non-injection drug users in New York City. J Urban Health. 2004;81(1):20-24.
25. Ompad DC, Galea S, Wu Y, et al. Acceptance and completion of hepatitis B vaccination among drug users in New York City. Commun Dis Public Health. 2004;7(4):294-300.
26. Ompad DC, Galea S, Fuller CM, Phelan D, Vlahov D. Club drug use among minority substance users in New York City. J Psychoact Drugs. 2004;36(3):397-399.
27. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. National HIV Prevention Conference, Atlanta, Georgia, Jun 12-15, 2005; Atlanta, Georgia.
28. Des Jarlais DC, Arasteh K, Perlis T, et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS. 2007;21(2):231-235.
29. Des Jarlais, Perlis T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS. 2005;19(Suppl 3):S20-S25.
30. Tortu S, McMahon JM, Pouget ER, Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst Use Misuse. 2004;39(2):211-224.
31. Kottiri BJ, Friedman SR, Euler GL, et al. A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City. J Urban Health. 2005;82(3):479-487.
32. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health. 1999;89(1):14-18.
33. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714.